VRViviana Ritacco

Viviana Ritacco

*This is an algorithmically generated author record based on publicly available information.

Viviana Ritacco has a total of 467 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment

    by Darío A. Fernandez Do Porto, Johana Monteserin, Josefina Campos, Ezequiel J. Sosa, Mario Matteo, Federico Serral, Noemí Yokobori, Andrés Fernández Benevento, Tomás Poklepovich, Agustín Pardo, et al.

    Background: Whole-genome sequencing has shown that the Mycobacterium tuberculosis infection process can be more heterogeneous than previously thought. Compartmentalized infections, exogenous reinfections, and microevolution are manifestations of this clonal complexity. The analysis of the mechanisms causing the microevolution —the genetic variability of M. tuberculosis at short time scales— of a parental strain into clonal variants with a patient is a relevant issue that has not been yet completely addressed. To our knowledge, a whole genome sequence microevolution analysis in a single patient with inadequate adherence to treatment has not been previously reported. Case presentation: In this work, we applied whole genome sequencing analysis for a more in-depth analysis of the microevolution of a parental Mycobacterium tuberculosis strain into clonal variants within a patient with poor treatment compliance in Argentina. We analyzed the whole-genome sequence of 8 consecutive Mycobacterium tuberculosis isolates obtained from a patient within 57-months of intermittent therapy. Nineteen mutations (9 short-term, 10 fixed variants) emerged, most of them associated with drug resistance. The first isolate was already resistant to isoniazid, rifampicin, and streptomycin, thereafter the strain developed resistance to fluoroquinolones and pyrazinamide. Surprisingly, isolates remained susceptible to the pro-drug ethionamide after acquiring a frameshift mutation in ethA, a gene required for its activation. We also found a novel variant, (T-54G), in the 5′ untranslated region of whiB7 (T-54G), a region allegedly related to kanamycin resistance. Notably, discrepancies between canonical and phage-based susceptibility testing to kanamycin were previously found for the isolate harboring this mutation. In our patient, microevolution was mainly driven by drug selective pressure. Rare short-term mutations fixed together with resistance-conferring mutations during therapy. Conclusions: This report highlights the relevance of whole-genome sequencing analysis in the clinic for characterization of pre-XDR and MDR resistance profile, particularly in patients with incomplete and/or intermittent treatment.


  • Recurrences of multidrug‐resistant tuberculosis: Strains involved, within‐host diversity, and fine‐tuned allocation of reinfections

    by Laura Pérez‐Lago, Johana Monteserin, Roxana Paul, Sandra R. Maus, Noemí Yokobori, Marta Herranz, Jon Sicilia, Fermín Acosta, Sandra Fajardo, Álvaro Chiner‐Oms, et al.

    Recurrent tuberculosis occurs due to exogenous reinfection or reactivation/persistence. We analysed 90 sequential MDR Mtb isolates obtained in Argentina from 27 patients with previously diagnosed MDR‐TB that recurred in 2018 (1–10 years, 2–10 isolates per patient). Three long‐term predominant strains were responsible for 63% of all MDR‐TB recurrences. Most of the remaining patients were infected by strains different from each other. Reactivation/persistence of the same strain caused all but one recurrence, which was due to a reinfection with a predominant strain. One of the prevalent strains showed marked stability in the recurrences, while in another strain higher SNP‐based diversity was observed. Comparisons of intra‐ versus inter‐patient SNP distances identified two possible reinfections with closely related variants circulating in the community. Our results show a complex scenario of MDR‐TB infections in settings with predominant MDR Mtb strains.


    • 1 December 2020
      • Vol. 80, 117-118

    Tuberculosis and COVID-19: a dangerous liaison

    by Viviana Ritacco, Isabel N. Kantor


  • Open Access

    Association between bacterial homoplastic variants and radiological pathology in tuberculosis

    by Louis Grandjean, Joha Monteserin, Robert Gilman, Julia Pauschardt, Sakib Rokadiya, Cesar Bonilla, Viviana Ritacco, Julia Rios Vidal, Julian Parkhill, Sharon Peacock, et al.

    Background: Understanding how pathogen genetic factors contribute to pathology in TB could enable tailored treatments to the most pathogenic and infectious strains. New strategies are needed to control drug-resistant TB, which requires longer and costlier treatment. We hypothesised that the severity of radiological pathology on the chest radiograph in TB disease was associated with variants arising independently, multiple times (homoplasies) in theMycobacterium tuberculosisgenome.Methods: We performed whole genome sequencing (Illumina HiSeq2000 platform) onM. tuberculosisisolates from 103 patients with drug-resistant TB in Lima between 2010 and 2013. Variables including age, sex, HIV status, previous TB disease and the percentage of lung involvement on the pretreatment chest radiograph were collected from health posts of the national TB programme. Genomic variants were identified using standard pipelines.Results: Two mutations were significantly associated with more widespread radiological pathology in a multivariable regression model controlling for confounding variables (Rv2828c.141, RR 1.3, 95% CI 1.21 to 1.39, pM. tuberculosisgenome to radiological pathology on the chest radiograph. We identified two variants significantly positively associated with more widespread radiological pathology and one with reduced pathology. Prospective studies are warranted to determine whether mutations associated with increased pathology also predict the spread of drug-resistant TB.


    • 1 June 2020
      • Vol. 80, 87-88

    About population tests to detect anti-SARS-CoV-2 antibodies

    by Isabel N. Kantor, Viviana Ritacco

  • Open Access

    A Phenotypic Characterization of Two Isolates of a Multidrug‐Resistant Outbreak Strain of Mycobacterium tuberculosis with Opposite Epidemiological Fitness

    by Jinlong Bei, María Mercedes Bigi, Analía Lima, Qi Zhang, Federico Carlos Blanco, Beatriz Lopez, Ting Yu, Zhilin Wang, Zhangyan Dai, Zhuang Chen, et al.

    Tuberculosis (TB) is an infectious disease, caused by Mycobacterium tuberculosis, primarily affecting the lungs. The M. tuberculosis strain of the Haarlem family named M was responsible for a large multidrug‐resistant TB (MDR‐TB) outbreak in Buenos Aires. This outbreak started in the early 1990s and in the mid 2000s still accounted for 29% of all MDR‐TB cases in Argentina. By contrast, a clonal variant of strain M, named 410, has caused a single tuberculosis case since the onset of the outbreak. The molecular bases of the high epidemiological fitness of the M strain remain unclear. To assess its unique molecular properties, herein, we performed a comparative protein and lipid analysis of a representative clone of the M strain (Mp) and the nonprosperous M variant 410. We also evaluated their growth in low pH. The variant 410 had higher levels of latency proteins under standard conditions and delayed growth at low pH, suggesting that it is more sensitive to stress stimuli than Mp. Moreover, Mp showed higher levels of mycolic acids covalently attached to the cell wall and lower accumulation of free mycolic acids in the outer layer than the 410 strain. The low expression of latency proteins together with the reduced content of surface mycolic acids may facilitate Mp to evade the host immune responses.


  • Trends of Two Epidemic Multidrug-Resistant Strains of Mycobacterium tuberculosis in Argentina Disclosed by Tailored Molecular Strategy

    by Johana Monteserin, Laura Pérez-Lago, Noemí Yokobori, Roxana Paul, Sandra Rodríguez Maus, Norberto Simboli, Vegard Eldholm, Beatriz López, Darío García de Viedma, Viviana Ritacco

    Two Mycobacterium tuberculosis strains—M (sublineage 4.1) and Ra (sublineage 4.3)—have long prevailed in Argentina among patients with multidrug-resistant tuberculosis (MDR-TB). Recently, budget constraints have hampered the surveillance of MDR-TB transmission. Based on whole-genome sequence analysis, we used M- and Ra-specific single nucleotide polymorphisms to tailor two multiplex allele-specific polymerase chain reactions (PCRs), which we applied to 252 stored isolates (95% of all newly diagnosed MDR-TB cases countrywide, 2015–2017). Compared with the latest data available (2007–2009), the M strain has receded (80/324 to 20/252, P < 0.0001), particularly among cross-border migrants (12/58 to 0/53, P = 0.0003) and HIV-infected people (30/97 to 7/74, P = 0.0007), but it still accounts for 4/12 new cases of extensively drug-resistant TB. Differently, the Ra strain remained stable in frequency (39/324 to 33/252) and contributed marginally to the extensive drug-resistance load (1/12). Our novel strategy disclosed recent trends of the two major MDR-TB strains, providing meaningful data to allocate control interventions more efficiently.


  • Survival of an epidemic MDR strain of Mycobacterium tuberculosis and its non-prosperous variant within activated macrophages

    by Noemí Yokobori, Johana Monteserin, Bárbara Rearte, Roxana Paul, Norberto Símboli, Beatriz López, Viviana Ritacco, María del Carmen Sasiain


  • Open Access

    Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation

    by Ola B. Brynildsrud, Caitlin S. Pepperell, Philip Suffys, Louis Grandjean, Johana Monteserin, Nadia Debech, Jon Bohlin, Kristian Alfsnes, John O.-H. Pettersson, Ingerid Kirkeleite, et al.

    On the basis of population genomic and phylogeographic analyses of 1669 Mycobacterium tuberculosis lineage 4 (L4) genomes, we find that dispersal of L4 has been completely dominated by historical migrations out of Europe. We demonstrate an intimate temporal relationship between European colonial expansion into Africa and the Americas and the spread of L4 tuberculosis (TB). Markedly, in the age of antibiotics, mutations conferring antimicrobial resistance overwhelmingly emerged locally (at the level of nations), with minimal cross-border transmission of resistance. The latter finding was found to reflect the relatively recent emergence of these mutations, as a similar degree of local restriction was observed for susceptible variants emerging on comparable time scales. The restricted international transmission of drug-resistant TB suggests that containment efforts at the level of individual countries could be successful.